IgG avidity: Role in infectious disease;L'avidité des IgG: Implications en infectiologie

Immuno-Analyse et Biologie Specialisee

Volumn 16, Issue 2, 2001, Pages 87-91

  Grangeot Keros, L ^a  

^a Service de Microbiologie immunologie   (France)

Author keywords

avidit des IgG; IgG avidity; infection materno f tale; materno fetal infection; primary infection; primo infection; protection

Indexed keywords

IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G;

ANTIBODY PRODUCTION; BINDING AFFINITY; HUMAN; IMMUNITY; IMMUNOCOMPETENCE; IMMUNOGLOBULIN GENE; IMMUNOPATHOLOGY; INTRAUTERINE INFECTION; MOTHER FETUS RELATIONSHIP; PATHOPHYSIOLOGY; PERINATAL INFECTION; PERINATAL PERIOD; PREGNANCY; PRENATAL PERIOD; PRIMARY INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; SOMATIC MUTATION;

EID: 4344562976     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2532(01)80057-0     Document Type: Review

References (21)

1. Bottiger B, Jensen IP. Maturation of rubella IgG avidity overtime after acute rubella infection. Clin Diagn Virol. 2:1997;105-111
2. Ciofu O, Petersen TD, Jensen P, Hoiby N. Avidity of anti-P. aeruginosa antibodies during chronic infection in patients with cystic fibrosis. Thorax. 54:1999;141-144
3. Cozon GJN, Ferrandiz J, Nebhi H, Wallon M, Peyron F. Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women. Eur J Clin Microbiol Infect Dis. 17:1998;32-36
4. Dussaix E, Chantot S, Harzic M, Grangeot-Keros L. CMV-IgG avidity and CMV IgM concentration in both immunocompromised and immunocompetent patients. Pathol Biol. 44:1996;405-410
5. Grangeot-Keros L, Lebon P, Freymuth F, Eugene G, Stricker R, Dussaix E. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis. 175:1997;944-946
6. Grangeot-Keros L, Simon B, Audibert F, Vial M. Should we routinely screen for cytomegalovirus antibody during pregnancy. Intervirol. 41:1998;158-162
7. Hedman K, Hietala J, Tiilikainen A, Hartikainen-Sorri A.L., Räihä K, Suni J, Väänänen P, Pietiläinen M. Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing. J Med Virol. 27:1989;293-298
8. Hedman K, Lappalainen M, Söderlund M, Hedman L. Avidity of IgG in serodiagnosis of infectious diseases. Rev Med Microbiol. 4:1993;123-129
9. Inouye S, Hasegawa A, Matsuno S, Katow S. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol. 20:1984;525-529
10. Junker A.K., Tilley P. Varicella-zoster virus antibody avidity and IgG-subclass patterns in children with recurrent chickenpox. J Med Virol. 43:1994;119-124
11. Lazzarotto T, Varani S, Spezzacatena P, Pradelli P, Potena L, Lombardi A, Ghisetti V, Gabrielli L, Abate DA, Magelli C, Landini MP. Delayed acquisition of high-avidity anti-cytomegalovirus antibody is correlated with prolonged antigenemia in solid organ transplant recipients. J Infect Dis. 178:1998;1145-1149
12. Lecolier B, Pucheu B. Intérêt de l'étude de l'avidité des IgG pour le diagnostic de la toxoplasmose. Pathol Biol. 41:1993;155-158
13. Mauracher CA, Mitchell LA, Tingle AJ. Differential IgG avidity to rubella virus structural proteins. J Med Virol. 3:1992;202-208
14. Mellander L, Bottiger M, Hanson LA, Taranger J, Carlsson B. Avidity and titers of the antibody response to two inactivated poliovirus vaccines with different antigen content. Acta Paediatr. 82:1993;552-556
15. Nossal GJV. The molecular and cellular basis of affinity maturation in the antibody response. Cell. 68:1992;1-2
16. Pelloux H, Brun E, Vernet G, Marcillat S, Jolivet M, Guergour D, Fricker-Hidalgo H, Goullier-Fleuret A, Ambroise-Thomas P. Determination of anti-toxoplasma gondii immunoglobulin G avidity: adaptation to the Vidas system (Bio Mérieux). Diagn Microbiol Infect dis. 32:1998;69-73
17. Pullen GR, Fitzgerald MG, Hosking CS. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods. 106:1986;191-194
18. Simon F, Rahimy C, Krivine A, Levine M, Pepin JM, Lapierre D, Denamur E, Vernoux L, De Crepy A, Blot P, et al. Antibody avidity measurement and immune complex dissociation for serological diagnosis of vertically acquired HIV-1 infection. J Acquir Immune defic syndr. 6:1993;201-207
19. Thomas HIJ, Morgan-Capner P. The use of antibody avidity measurement for the diagnosis of rubella. Rev Med Virol. 1:1991;41-50
20. Thomas HIJ, Morgan-Capner P, Cradock-Watson JE, Enders G, Best JM, O'Shea S. Slow maturation of IgG1 avidity and persistence of specific IgM in congenital rubella implications for diagnosis and immunopathology. J Med Virol. 41:1993;196-200
21. Usinger WR, Lucas AH. Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides. Infect Immun. 67:1999;2366-2370